Associate Professor of Psychiatry, Part-time
Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K
Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999 Jan-Mar; 52(1-3):135-44.
Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?
Clinical practice guidelines: praise and problems. J Clin Psychiatry. 1999 Jan; 60(1):7-8.
Clinical practice guidelines: praise and problems.
The treatment of bipolar depression. Bipolar Disord. 2000 Sep; 2(3 Pt 2):256-60.
Characteristics of rapid cycling bipolar-I patients in a bipolar speciality clinic. J Affect Disord. 2004 Apr; 79(1-3):247-51.
Characteristics of rapid cycling bipolar-I patients in a bipolar speciality clinic.
Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. J Affect Disord. 2009 Jul; 116(1-2):43-50.
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Adding a nurse-based intervention programme to usual care improves manic symptoms in people with bipolar disorder. Evid Based Ment Health. 2005 Aug; 8(3):81.
Adding a nurse-based intervention programme to usual care improves manic symptoms in people with bipolar disorder.
Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, Sachs G
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. Psychiatr Serv. 2006 May; 57(5):660-5.
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Casamassima F, Huang J, Fava M, Sachs GS, Smoller JW, Cassano GB, Lattanzi L, Fagerness J, Stange JP, Perlis RH
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 05; 153B(1):303-9.
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder.
Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J, Sachs GS, Nimgaonkar V, Scolnick EM, Gurling H, Sklar P, Purcell S
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009 Jun; 166(6):718-25.
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.
Three patients with concomitant panic attacks and seizure disorder: possible clues to the neurology of anxiety. Am J Psychiatry. 1987 Aug; 144(8):1053-6.
Three patients with concomitant panic attacks and seizure disorder: possible clues to the neurology of anxiety.
[Diet triggered depression as well as its treatment: a behaviorally oriented group therapy concept]. Psychiatr Clin (Basel). 1982; 15(3):160-72.
[Diet triggered depression as well as its treatment: a behaviorally oriented group therapy concept].
Ghaemi SN, Sachs GS, Baldassano CF, Truman CJ
Insight in seasonal affective disorder. Compr Psychiatry. 1997 Nov-Dec; 38(6):345-8.
Bayle D, Wängler S, Weitzenegger T, Steinhilber W, Volz J, Przybylski M, Schäfer KP, Sachs G, Melchers K
Properties of the P-type ATPases encoded by the copAP operons of Helicobacter pylori and Helicobacter felis. J Bacteriol. 1998 Jan; 180(2):317-29.
Properties of the P-type ATPases encoded by the copAP operons of Helicobacter pylori and Helicobacter felis.
Lafer B, Sachs GS, Labbate LA, Thibault A, Rosenbaum JF
Phototherapy for seasonal affective disorder: a blind comparison of three different schedules. Am J Psychiatry. 1994 Jul; 151(7):1081-3.
Phototherapy for seasonal affective disorder: a blind comparison of three different schedules.
Phototherapy-induced hot flushes. J Clin Psychopharmacol. 1994 Apr; 14(2):151.
Implementing evidence-based treatment of manic and mixed episodes. J Clin Psychiatry. 2006; 67 Suppl 11:12-7.
Implementing evidence-based treatment of manic and mixed episodes.
Yildiz A, Demopulos CM, Moore CM, Renshaw PF, Sachs GS
Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled (31)P magnetic resonance spectroscopy study. Biol Psychiatry. 2001 Jul 01; 50(1):3-7.
Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled (31)P magnetic resonance spectroscopy study.
Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002 Jul; 159(7):1146-54.
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Marangell LB, Martinez JM, Ketter TA, Bowden CL, Goldberg JF, Calabrese JR, Miyahara S, Miklowitz DJ, Sachs GS, Thase ME
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. Bipolar Disord. 2004 Apr; 6(2):139-43.
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Perlis RH, Ostacher M, Fava M, Nierenberg AA, Sachs GS, Rosenbaum JF
Assuring that double-blind is blind. Am J Psychiatry. 2010 Mar; 167(3):250-2.
Sachs GS, Gaulin BD, Gutierrez-Esteinou R, McQuade RD, Pikalov A, Pultz JA, Sanchez R, Marcus RN, Crandall DT
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. J Clin Psychiatry. 2007 Sep; 68(9):1377-83.
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS
Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006 Jun 01; 59(11):1078-86.
Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006 Feb; 163(2):217-24.
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Allen MH, Chessick CA, Miklowitz DJ, Goldberg JF, Wisniewski SR, Miyahara S, Calabrese JR, Marangell L, Bauer MS, Thomas MR, Bowden CL, Sachs GS
Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts. Suicide Life Threat Behav. 2005 Dec; 35(6):671-80.
Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts.
Regulation of intracellular calcium in epithelial cells. Semin Cell Biol. 1990 Aug; 1(4):305-10.
Regulation of intracellular calcium in epithelial cells.
Miklowitz DJ, Otto MW, Wisniewski SR, Araga M, Frank E, Reilly-Harrington NA, Lembke A, Sachs GS
Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. Psychiatr Serv. 2006 Jul; 57(7):959-65.
Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.
Henin A, Biederman J, Mick E, Hirshfeld-Becker DR, Sachs GS, Wu Y, Yan L, Ogutha J, Nierenberg AA
Childhood antecedent disorders to bipolar disorder in adults: a controlled study. J Affect Disord. 2007 Apr; 99(1-3):51-7.
Childhood antecedent disorders to bipolar disorder in adults: a controlled study.
Psychosocial strategies to improve concordance and adherence in bipolar disorder. J Clin Psychiatry. 2006 Jul; 67(7):e04.
Psychosocial strategies to improve concordance and adherence in bipolar disorder.
Psychosocial interventions as adjunctive therapy for bipolar disorder. J Psychiatr Pract. 2008 May; 14 Suppl 2:39-44.
Psychosocial interventions as adjunctive therapy for bipolar disorder.
Gruber J, Harvey AG, Wang PW, Brooks JO, Thase ME, Sachs GS, Ketter TA
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord. 2009 Apr; 114(1-3):41-9.
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Gelenberg AJ, Bellinghausen B, Wojcik JD, Falk WE, Sachs GS
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry. 1988 Apr; 145(4):517-8.
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital.
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS
Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
Does recovery from substance use disorder matter in patients with bipolar disorder?
Miklowitz DJ, Wisniewski SR, Miyahara S, Otto MW, Sachs GS
Perceived criticism from family members as a predictor of the one-year course of bipolar disorder. Psychiatry Res. 2005 Sep 15; 136(2-3):101-11.
Perceived criticism from family members as a predictor of the one-year course of bipolar disorder.
Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T
Journal of psychopharmacology (Oxford, England)
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol. 2006 Jul; 20(4):536-46.
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Sachs G, Bowden C, Calabrese JR, Ketter T, Thompson T, White R, Bentley B
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord. 2006 Apr; 8(2):175-81.
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.
Inhibition of the human sodium/bile acid cotransporters by side-specific methanethiosulfonate sulfhydryl reagents: substrate-controlled accessibility of site of inactivation. Biochemistry. 2000 Jun 06; 39(22):6743-50.
Inhibition of the human sodium/bile acid cotransporters by side-specific methanethiosulfonate sulfhydryl reagents: substrate-controlled accessibility of site of inactivation.
Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000 Nov; 61(11):841-50.
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
Sachs GS, Gelenberg AJ, Bellinghausen B, Wojcik J, Falk WE, Farhadi AM, Jenike M
Ergoloid mesylates and ECT. J Clin Psychiatry. 1989 Mar; 50(3):87-90.
Unmet clinical needs in bipolar disorder. J Clin Psychopharmacol. 2003 Jun; 23(3 Suppl 1):S2-8.
Unmet clinical needs in bipolar disorder.
Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010 Apr; 71(4):372-80.
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry. 2010 Oct; 167(10):1254-63.
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
Weilburg JB, Schachter S, Sachs GS, Worth J, Pollack MH, Ives JR, Schomer DL
The Journal of neuropsychiatry and clinical neurosciences
Focal paroxysmal EEG changes during atypical panic attacks. J Neuropsychiatry Clin Neurosci. 1993; 5(1):50-5.
Focal paroxysmal EEG changes during atypical panic attacks.
Zhang H, Wisniewski SR, Bauer MS, Sachs GS, Thase ME
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry. 2006 May-Jun; 47(3):161-8.
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9.
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH
The British journal of psychiatry : the journal of mental science
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
Acta psychiatrica Scandinavica. Supplementum
Adjunctive treatment of acute mania: a clinical overview. Acta Psychiatr Scand Suppl. 2007; (434):27-34.
Adjunctive treatment of acute mania: a clinical overview.
Tesar GE, Rosenbaum JF, Pollack MH, Herman JB, Sachs GS, Mahoney EM, Cohen LS, McNamara M, Goldstein S
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Pump blockers and ulcer disease. N Engl J Med. 1984 Mar 22; 310(12):785-6.
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009 Aug; 11(5):453-73.
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
González RG, Guimaraes AR, Sachs GS, Rosenbaum JF, Garwood M, Renshaw PF
AJNR. American journal of neuroradiology
Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am J Neuroradiol. 1993 Sep-Oct; 14(5):1027-37.
Measurement of human brain lithium in vivo by MR spectroscopy.
El-Mallakh RS, Ghaemi SN, Sagduyu K, Thase ME, Wisniewski SR, Nierenberg AA, Zhang HW, Pardo TA, Sachs G
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. J Affect Disord. 2008 Dec; 111(2-3):372-7.
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. Psychopharmacol Bull. 2009; 42(1):35-49.
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing.
Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TB, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel JK, Sachs GS, Thase ME, Molay FB, Escamilla MA, Nimgaonkar VL, Sklar P, Laird NM, Smoller JW
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 05; 153B(1):29-37.
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
Sachs G, Rasoul-Rockenschaub S, Aschauer H, Spiess K, Göber I, Staffen A, Zielinski C
Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study. J Neuroimmunol. 1995 Jun; 59(1-2):83-9.
Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study.
Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS
Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord. 2019 01 15; 243:116-120.
Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression.
Hoge SK, Sachs G, Appelbaum PS, Greer A, Gordon C
Limitations on psychiatrists' discretionary civil commitment authority by the Stone and dangerousness criteria. Arch Gen Psychiatry. 1988 Aug; 45(8):764-9.
Limitations on psychiatrists' discretionary civil commitment authority by the Stone and dangerousness criteria.
Triazolam-induced brief episodes of secondary mania in a depressed patient. J Clin Psychiatry. 1987 Dec; 48(12):492-3.
Triazolam-induced brief episodes of secondary mania in a depressed patient.
Sachs GS, Renshaw PF, Lafer B, Stoll AL, Guimarães AR, Rosenbaum JF, Gonzalez RG
Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry. 1995 Oct 01; 38(7):422-8.
Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study.
Deckersbach T, Perlis RH, Frankle WG, Gray SM, Grandin L, Dougherty DD, Nierenberg AA, Sachs GS
Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr. 2004 Mar; 9(3):227-31.
Presence of irritability during depressive episodes in bipolar disorder.
Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry. 2004 Apr; 184:337-45.
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2006 Jan; 67(1):48-55.
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Bauer MS, Wisniewski SR, Kogan JN, Marangell LB, Thase ME, Sachs G
Brief report: paroxetine in younger and adult individuals at high risk for suicide. Psychopharmacol Bull. 2006; 39(1):31-7.
Brief report: paroxetine in younger and adult individuals at high risk for suicide.
Ostacher MJ, Nierenberg AA, Perlis RH, Eidelman P, Borrelli DJ, Tran TB, Marzilli Ericson G, Weiss RD, Sachs GS
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry. 2006 Dec; 67(12):1907-11.
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
Ostacher MJ, Nierenberg AA, Iosifescu DV, Eidelman P, Lund HG, Ametrano RM, Kaczynski R, Calabrese J, Miklowitz DJ, Sachs GS, Perlick DA
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder. Acta Psychiatr Scand. 2008 Jul; 118(1):49-56.
Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009 Feb; 166(2):173-81.
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009 Nov; 11(7):701-10.
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depression. Ann Clin Psychiatry. 2018 11; 30(4):296-304.
Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depression.
Baldassano CF, Truman CJ, Nierenberg A, Ghaemi SN, Sachs GS
Akathisia: a review and case report following paroxetine treatment. Compr Psychiatry. 1996 Mar-Apr; 37(2):122-4.
Akathisia: a review and case report following paroxetine treatment.
Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF
A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994 Sep; 55(9):391-3.
A double-blind trial of bupropion versus desipramine for bipolar depression.
The primary care companion for CNS disorders
Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression. Prim Care Companion CNS Disord. 2018 Nov 01; 20(6).
Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression.
Kupfer DJ, Chengappa KN, Gelenberg AJ, Hirschfeld RM, Goldberg JF, Sachs GS, Grochocinski VJ, Houck PR, Kolar AB
Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry. 2001 Dec; 62(12):985-90.
Citalopram as adjunctive therapy in bipolar depression.
Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? J Clin Psychiatry. 2003; 64 Suppl 6:18-22; discussion 28.
Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals?
Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA, Baker RW, Tohen M
Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol. 2003 Aug; 23(4):370-6.
Olanzapine versus placebo in acute mania: treatment responses in subgroups.
Deckersbach T, McMurrich S, Ogutha J, Savage CR, Sachs G, Rauch SL
Characteristics of non-verbal memory impairment in bipolar disorder: the role of encoding strategies. Psychol Med. 2004 Jul; 34(5):823-32.
Characteristics of non-verbal memory impairment in bipolar disorder: the role of encoding strategies.
Henin A, Biederman J, Mick E, Sachs GS, Hirshfeld-Becker DR, Siegel RS, McMurrich S, Grandin L, Nierenberg AA
Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry. 2005 Oct 01; 58(7):554-61.
Psychopathology in the offspring of parents with bipolar disorder: a controlled study.
Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME, Calabrese JR, Marangell LB, Ostacher MJ, Patel J, Thomas MR, Araga M, Gonzalez JM, Wisniewski SR
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry. 2007 Sep; 164(9):1340-7.
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
Nowakowska C, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Ketter TA
Increased rate of non-right-handedness in patients with bipolar disorder. J Clin Psychiatry. 2008 May; 69(5):866-7.
Increased rate of non-right-handedness in patients with bipolar disorder.
Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.
Moser G, Kiss A, Sachs G, Spiess K, Schwarzmeier J
Psychotherapie, Psychosomatik, medizinische Psychologie
[The significance of psychosocial complaints in the initial interview--a study of unselected patients of an internal medicine/polyclinic university ambulatory service]. Psychother Psychosom Med Psychol. 1989 May; 39(5):161-7.
[The significance of psychosocial complaints in the initial interview--a study of unselected patients of an internal medicine/polyclinic university ambulatory service].
Chitayat D, Hahm SY, Marion RW, Sachs GS, Goldman D, Hutcheon RG, Weiss R, Cho S, Nitowsky HM
American journal of diseases of children (1960)
Further delineation of the McKusick-Kaufman hydrometrocolpos-polydactyly syndrome. Am J Dis Child. 1987 Oct; 141(10):1133-6.
Further delineation of the McKusick-Kaufman hydrometrocolpos-polydactyly syndrome.
Kraut JA, Hiura J, Shin JM, Smolka A, Sachs G, Scott D
The Na(+)-K(+)-ATPase beta 1 subunit is associated with the HK alpha 2 protein in the rat kidney. Kidney Int. 1998 Apr; 53(4):958-62.
The Na(+)-K(+)-ATPase beta 1 subunit is associated with the HK alpha 2 protein in the rat kidney.
Lambrecht N, Corbett Z, Bayle D, Karlish SJ, Sachs G
Identification of the site of inhibition by omeprazole of a alpha-beta fusion protein of the H,K-ATPase using site-directed mutagenesis. J Biol Chem. 1998 May 29; 273(22):13719-28.
Identification of the site of inhibition by omeprazole of a alpha-beta fusion protein of the H,K-ATPase using site-directed mutagenesis.
Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002 Jan; 59(1):62-9.
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Do antidepressants induce rapid cycling? A gender-specific association. J Clin Psychiatry. 2003 Jul; 64(7):814-8.
Do antidepressants induce rapid cycling? A gender-specific association.
Clonazepam vs. neuroleptics as adjuncts to lithium maintenance. Psychopharmacol Bull. 1990; 26(1):137-43.
Clonazepam vs. neuroleptics as adjuncts to lithium maintenance.
Perlis RH, Ostacher MJ, Miklowitz DJ, Hay A, Nierenberg AA, Thase ME, Sachs GS
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J Clin Psychiatry. 2010 Mar; 71(3):296-303.
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
Sylvia LG, Dupuy JM, Ostacher MJ, Cowperthwait CM, Hay AC, Sachs GS, Nierenberg AA, Perlis RH
Sleep disturbance in euthymic bipolar patients. J Psychopharmacol. 2012 Aug; 26(8):1108-12.
Sleep disturbance in euthymic bipolar patients.
Earley W, Burgess MV, Rekeda L, Dickinson R, Szatmári B, Németh G, McIntyre RS, Sachs GS, Yatham LN
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. Am J Psychiatry. 2019 06 01; 176(6):439-448.
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Assistant Professor of Psychology in the Department of Psychiatry
Assistant Professor of Psychology in the Department of Psychiatry, Part-time
Associate Professor of Psychology in the Department of Psychiatry
Ma Y, Ji J, Huang Y, Gao H, Li Z, Dong W, Zhou S, Zhu Y, Dang W, Zhou T, Yu H, Yu B, Long Y, Liu L, Sachs G, Yu X
Implementing machine learning in bipolar diagnosis in China. Transl Psychiatry. 2019 11 18; 9(1):305.
Implementing machine learning in bipolar diagnosis in China.
Vieta E, Sachs G, Chang D, Hellsten J, Brewer C, Peters-Strickland T, Hefting N
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania. J Psychopharmacol. 2021 Aug; 35(8):971-982.
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania.
Calabrese JR, Durgam S, Satlin A, Vanover KE, Davis RE, Chen R, Kozauer SG, Mates S, Sachs GS
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. Am J Psychiatry. 2021 12; 178(12):1098-1106.
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Woodward DF, Krauss AH, Chen J, Gil DW, Kedzie KM, Protzman CE, Shi L, Chen R, Krauss HA, Bogardus A, Dinh HT, Wheeler LA, Andrews SW, Burk RM, Gac T, Roof MB, Garst ME, Kaplan LJ, Sachs G, Pierce KL, Regan JW, Ross RA, Chan MF
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds. Br J Pharmacol. 2000 Aug; 130(8):1933-43.
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Durgam S, Chen R, Calabrese JR, Sachs GS
Treatments for Depression in Bipolar II Disorder. Am J Psychiatry. 2022 09; 179(9):688-690.
Treatments for Depression in Bipolar II Disorder.
Sachs GS, Yeung PP, Rekeda L, Khan A, Adams JL, Fava M
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Am J Psychiatry. 2023 03 01; 180(3):241-251.
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Riesenberg R, Yeung PP, Rekeda L, Sachs GS, Kerolous M, Fava M
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study. J Clin Psychiatry. 2023 08 16; 84(5).
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
Horan WP, Sachs G, Velligan DI, Davis M, Keefe RSE, Khin NA, Butlen-Ducuing F, Harvey PD
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward. Innov Clin Neurosci. 2024 Jan-Mar; 21(1-3):19-30.
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward.
Spiess K, Sachs G, Frischenschlager O, Moser G, Prager R
Zeitschrift fur Psychosomatische Medizin und Psychoanalyse
[Phase-specific function of denial in type 1 diabetic patients after disease onset]. Z Psychosom Med Psychoanal. 1994; 40(1):52-67.
[Phase-specific function of denial in type 1 diabetic patients after disease onset].
Nutzinger DO, Cayiroglu S, Sachs G, Zapotoczky HG
Journal of behavior therapy and experimental psychiatry
Emotional problems during weight reduction: advantages of a combined behavior therapy and antidepressive drug therapy for obesity. J Behav Ther Exp Psychiatry. 1985 Sep; 16(3):217-21.
Emotional problems during weight reduction: advantages of a combined behavior therapy and antidepressive drug therapy for obesity.
Moser G, Tillinger W, Sachs G, Maier-Dobersberger T, Wyatt J, Vogelsang H, Lochs H, Gangl A
Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res. 1996 May; 40(5):503-9.
Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease.
Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, Wyatt J, Vogelsang H, Lochs H, Gangl A
European journal of gastroenterology & hepatology
Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995 Sep; 7(9):853-8.
Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease.
[Functional MRI in schizophrenia. Diagnostics and therapy monitoring of cognitive deficits of schizophrenic patients by functional MRI]. Radiologe. 2010 Feb; 50(2):131-5.
[Functional MRI in schizophrenia. Diagnostics and therapy monitoring of cognitive deficits of schizophrenic patients by functional MRI].
Nutzinger DO, Cayiroglu S, Sachs G, Stellamor M, Zapotoczky HG
[A behaviorally oriented group therapy concept for the treatment of a risk group of obese patients]. Psychother Psychosom Med Psychol. 1983 Sep; 33 Suppl 2:102-9.
[A behaviorally oriented group therapy concept for the treatment of a risk group of obese patients].
[Cognitive dysfunction in schizophrenic psychoses. Drug and psychological treatment choices]. Psychiatr Prax. 2001 Mar; 28(2):60-8.
[Cognitive dysfunction in schizophrenic psychoses. Drug and psychological treatment choices].
Sachs G, Winklbaur B, Jagsch R, Keefe RS
European psychiatry : the journal of the Association of European Psychiatrists
Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results. Eur Psychiatry. 2011 Mar; 26(2):74-7.
Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results.
Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH
Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol. 2013 Jun; 33(3):343-50.
Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.
Unmet needs in the assessment and management of bipolar I depression. J Clin Psychiatry. 2013 Jun; 74(6):e11.
Unmet needs in the assessment and management of bipolar I depression.
Spiess K, Sachs G, Moser G, Pietschmann P, Schernthaner G, Prager R
Psychological moderator variables and metabolic control in recent onset type 1 diabetic patients--a two year longitudinal study. J Psychosom Res. 1994 Apr; 38(3):249-58.
Psychological moderator variables and metabolic control in recent onset type 1 diabetic patients--a two year longitudinal study.
Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med. 2010 Jan; 104(1):52-60.
Impact of chronic obstructive pulmonary disease (COPD) on attention functions.
Sachs GS, Vanderburg DG, Edman S, Karayal ON, Kolluri S, Bachinsky M, Cavus I
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection. J Clin Psychiatry. 2012 Nov; 73(11):1420-5.
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
Kemp DE, Karayal ON, Calabrese JR, Sachs GS, Pappadopulos E, Ice KS, Siu CO, Vieta E
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. Eur Neuropsychopharmacol. 2012 Feb; 22(2):123-31.
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Oct; 72(10):1413-22.
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2012 Nov; 73(11):1412-9.
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, Sachs GS, Ketter TA
Sleep matters: sleep functioning and course of illness in bipolar disorder. J Affect Disord. 2011 Nov; 134(1-3):416-20.
Sleep matters: sleep functioning and course of illness in bipolar disorder.
[Prevalence of psychiatric disorders in elderly inpatients of medical and surgical departments]. Psychiatr Prax. 2000 May; 27(4):170-5.
[Prevalence of psychiatric disorders in elderly inpatients of medical and surgical departments].
Sachs G, Winklbaur B, Jagsch R, Lasser I, Kryspin-Exner I, Frommann N, Wölwer W
Training of affect recognition (TAR) in schizophrenia--impact on functional outcome. Schizophr Res. 2012 Jul; 138(2-3):262-7.
Training of affect recognition (TAR) in schizophrenia--impact on functional outcome.
Lombardo I, Sachs G, Kolluri S, Kremer C, Yang R
Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? J Clin Psychopharmacol. 2012 Aug; 32(4):470-8.
Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?
Sachs G, Spiess K, Moser G, Kautzky A, Luger A, Pietschmann P, Schernthaner GS, Prager R
Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics. J Psychosom Res. 1993 Dec; 37(8):831-41.
Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics.
Moser G, Koppensteiner R, Eckersberger F, Klepetko W, Sachs G, Schlick W
Postoperative complication rate of thoracotomy in patients with normal and abnormal pulmonary function. Wien Klin Wochenschr. 1993; 105(3):71-5.
Postoperative complication rate of thoracotomy in patients with normal and abnormal pulmonary function.
Sachs G, Spiess K, Moser G, Prager R, Kunz A, Schernthaner G
[Glycosylated hemoglobin and diabetes--self monitoring (compliance) in depressed and non-depressed type I diabetic patients]. Psychother Psychosom Med Psychol. 1991 Aug; 41(8):306-12.
[Glycosylated hemoglobin and diabetes--self monitoring (compliance) in depressed and non-depressed type I diabetic patients].
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62.
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, Sachs G
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014 Feb; 171(2):160-8.
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
The international journal of neuropsychopharmacology
Polypharmacy and bipolar disorder: what's personality got to do with it? Int J Neuropsychopharmacol. 2014 Jul; 17(7):1053-61.
Polypharmacy and bipolar disorder: what's personality got to do with it?
Update on best practices for managing bipolar depression. J Clin Psychiatry. 2014 May; 75(5):e413-6.
Update on best practices for managing bipolar depression.
Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, Wheeler LA, Garst ME, Landsverk K, Sachs G, Krauss AH, Cornell C, Martos J, Pettit S, Fliri H
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br J Pharmacol. 2008 Jul; 154(5):1079-93.
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes.
Formica MJC, Fuller-Tyszkiewicz M, Reininghaus U, Kempton M, Delespaul P, de Haan L, Nelson B, Mikocka-Walus A, Olive L, Ruhrmann S, Rutten B, Riecher-Rössler A, Sachs G, Valmaggia L, van der Gaag M, McGuire P, van Os J, Hartmann JA
Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis. Psychol Med. 2024 Jul; 54(9):2254-2263.
Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis.
Kas MJH, Penninx BWJH, Knudsen GM, Cuthbert B, Falkai P, Sachs GS, Ressler KJ, Balkowiec-Iskra E, Butlen-Ducuing F, Leboyer M, Marston H, Luthman J, Mantua V
Precision psychiatry roadmap: towards a biology-informed framework for mental disorders. Mol Psychiatry. 2025 Aug; 30(8):3846-3855.
Precision psychiatry roadmap: towards a biology-informed framework for mental disorders.
Sachs GS, Greenberg WM, Starace A, Lu K, Ruth A, Laszlovszky I, Németh G, Durgam S
Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial. J Affect Disord. 2015 Mar 15; 174:296-302.
Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
Szabo ST, Kinon BJ, Brannan SK, Krystal AK, van Gerven JM, Mahableshwarkar A, Sachs GS
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments. Innov Clin Neurosci. 2015 Mar-Apr; 12(3-4):11S-25S.
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments.
Improving outcomes in patients with bipolar depression: a comprehensive review. J Clin Psychiatry. 2015 Mar; 76(3):e10.
Improving outcomes in patients with bipolar depression: a comprehensive review.
The Bipolarity Index: a clinician-rated measure of diagnostic confidence. J Affect Disord. 2015 May 15; 177:59-64.
The Bipolarity Index: a clinician-rated measure of diagnostic confidence.
Activation of apical chloride channels in the gastric oxyntic cell. Science. 1989 Jul 28; 245(4916):402-4.
Activation of apical chloride channels in the gastric oxyntic cell.
Proceedings of the National Academy of Sciences of the United States of America
Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6767-71.
Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase.
Hallén S, Björquist A, Ostlund-Lindqvist AM, Sachs G
Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry. 2002 Dec 17; 41(50):14916-24.
Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor.
Rabon E, Sachs G, Bassilian S, Leach C, Keeling D
A K(+)-competitive fluorescent inhibitor of the H,K-ATPase. J Biol Chem. 1991 Jul 05; 266(19):12395-401.
A K(+)-competitive fluorescent inhibitor of the H,K-ATPase.
Hallén S, Mareninova O, Brändén M, Sachs G
Organization of the membrane domain of the human liver sodium/bile acid cotransporter. Biochemistry. 2002 Jun 11; 41(23):7253-66.
Organization of the membrane domain of the human liver sodium/bile acid cotransporter.
Rabon EC, Bassilian S, Sachs G, Karlish SJ
Conformational transitions of the H,K-ATPase studied with sodium ions as surrogates for protons. J Biol Chem. 1990 Nov 15; 265(32):19594-9.
Conformational transitions of the H,K-ATPase studied with sodium ions as surrogates for protons.
Effects of mutations in M4 of the gastric H+,K+-ATPase on inhibition kinetics of SCH28080. Biochemistry. 2000 Mar 21; 39(11):2997-3004.
Effects of mutations in M4 of the gastric H+,K+-ATPase on inhibition kinetics of SCH28080.
Identification of H+/K(+)-ATPase alpha,beta-heterodimers. Biochim Biophys Acta. 1991 Apr 08; 1077(2):173-9.
Identification of H+/K(+)-ATPase alpha,beta-heterodimers.
The muscarinic receptor gene expressed in rabbit parietal cells is the m3 subtype. Gastroenterology. 1992 Sep; 103(3):870-5.
The muscarinic receptor gene expressed in rabbit parietal cells is the m3 subtype.
Zeng N, Kang T, Lyu RM, Wong H, Wen Y, Walsh JH, Sachs G, Pisegna JR
Annals of the New York Academy of Sciences
The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR. Ann N Y Acad Sci. 1998 Dec 11; 865:147-56.
The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.
Identification of membrane insertion sequences of the rabbit gastric cholecystokinin-A receptor by in vitro translation. J Biol Chem. 1997 Aug 08; 272(32):19697-707.
Identification of membrane insertion sequences of the rabbit gastric cholecystokinin-A receptor by in vitro translation.
Dar P, Sachs GS, Strassburger D, Bukovsky I, Arieli S
Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod. 2000 Jan; 15(1):142-4.
Ovarian function before and after salpingectomy in artificial reproductive technology patients.
Daniel D, Kalali A, West M, Walling D, Hilt D, Engelhardt N, Alphs L, Loebel A, Vanover K, Atkinson S, Opler M, Sachs G, Nations K, Brady C
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders. Innov Clin Neurosci. 2016 Jan-Feb; 13(1-2):27-33.
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders.
Ma Y, Gao H, Yu X, Si T, Wang G, Fang Y, Liu Z, Sun J, Yang H, Wang X, Li J, Zhang Y, Sachs G
Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index. J Affect Disord. 2016 Sep 15; 202:247-53.
Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index.
PILOT STUDY OF A CALCIUM CHANNEL BLOCKER IN FEMALES
Hlubocky FJ, Larson E, Ratain MJ, Sachs G, Daugherty CK
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Cognitive function (CF) and prognostic information understanding in advanced cancer patients (ACP). J Clin Oncol. 2009 May 20; 27(15_suppl):9516.
Cognitive function (CF) and prognostic information understanding in advanced cancer patients (ACP).
Diagnosing Mania in the Age of DSM-5. Am J Psychiatry. 2017 01 01; 174(1):8-10.
Matthew E, Vasile RG, Sachs G, Anderson J, Lafer B, Hill T
Regional cerebral blood flow changes after light therapy in seasonal affective disorder. Nucl Med Commun. 1996 Jun; 17(6):475-9.
Regional cerebral blood flow changes after light therapy in seasonal affective disorder.
Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF
Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry. 1996 Sep 01; 40(5):382-8.
Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
Goldstein LE, Sporn J, Brown S, Kim H, Finkelstein J, Gaffey GK, Sachs G, Stern TA
New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics. 1999 Sep-Oct; 40(5):438-43.
New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment.
Jain U, Blais MA, Otto MW, Hirshfeld DR, Sachs GS
Five-factor personality traits in patients with seasonal depression: treatment effects and comparisons with bipolar patients. J Affect Disord. 1999 Sep; 55(1):51-4.
Five-factor personality traits in patients with seasonal depression: treatment effects and comparisons with bipolar patients.
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2000 Sep; 61(9):638-42.
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Suppes T, Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RM, Keck PE, Sachs GS, Crismon ML, Toprac MG, Shon SP
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry. 2002 Apr; 63(4):288-99.
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.
The Psychiatric clinics of North America
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach. Psychiatr Clin North Am. 2003 Jun; 26(2):495-518.
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach.
Mansour HA, Talkowski ME, Wood J, Pless L, Bamne M, Chowdari KV, Allen M, Bowden CL, Calabrese J, El-Mallakh RS, Fagiolini A, Faraone SV, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TA, Loftis JM, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Thase ME, Frank E, Kupfer DJ, Nimgaonkar VL
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter. Ann Med. 2005; 37(8):590-602.
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Bowden CL, Ketter TA, Sachs GS, Thase ME
Focus on bipolar disorder treatment. J Clin Psychiatry. 2005 Dec; 66(12):1598-609.
Otto MW, Pollack MH, Rosenbaum JF, Sachs GS, Asher RH
Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93.
Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity.
Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, Sweitzer DE
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004 Jun; 6(3):213-23.
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
Kraut JA, Hiura J, Besancon M, Smolka A, Sachs G, Scott D
Effect of hypokalemia on the abundance of HK alpha 1 and HK alpha 2 protein in the rat kidney. Am J Physiol. 1997 Jun; 272(6 Pt 2):F744-50.
Effect of hypokalemia on the abundance of HK alpha 1 and HK alpha 2 protein in the rat kidney.
Bowden CL, Lecrubier Y, Bauer M, Goodwin G, Greil W, Sachs G
Maintenance therapies for classic and other forms of bipolar disorder. J Affect Disord. 2000 Sep; 59 Suppl 1:S57-S67.
Maintenance therapies for classic and other forms of bipolar disorder.
Otto MW, Pollack MH, Sachs GS, O'Neil CA, Rosenbaum JF
Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
Alcohol dependence in panic disorder patients.
Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, Lafer B, Gonzalez RG
The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1992 Nov 15; 32(10):944-9.
The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study.
Treatment-resistant bipolar depression. Psychiatr Clin North Am. 1996 Jun; 19(2):215-36.
Fishman SM, Catarau EM, Sachs G, Stojanovic M, Borsook D
Corticosteroid-induced mania after single regional application at the celiac plexus. Anesthesiology. 1996 Nov; 85(5):1194-6.
Corticosteroid-induced mania after single regional application at the celiac plexus.
The route of Ca2+ entry during reloading of the intracellular Ca2+ pool in pancreatic acini. J Biol Chem. 1990 Feb 05; 265(4):2011-6.
The route of Ca2+ entry during reloading of the intracellular Ca2+ pool in pancreatic acini.
Marangell LB, Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, Nierenberg A, Calabrese J, Wisniewski SR, Sachs G
Prostaglandins, leukotrienes, and essential fatty acids
Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov; 75(4-5):315-21.
Prostaglandins Leukot Essent Fatty Acids
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
Integration of suicide prevention into outpatient management of bipolar disorder. J Clin Psychiatry. 2001; 62 Suppl 25:3-11.
Integration of suicide prevention into outpatient management of bipolar disorder.
Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, Allen MH, Thase ME, Sachs GS
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008 Mar; 165(3):370-7; quiz 410.
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97.
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Yildiz A, Sachs GS, Dorer DJ, Renshaw PF
31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis. Psychiatry Res. 2001 May 30; 106(3):181-91.
31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness. World J Biol Psychiatry. 2000 Apr; 1(2):65-74.
What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness.
Pharmacological management of agitation in emergency settings. Emerg Med J. 2003 Jul; 20(4):339-46.
Pharmacological management of agitation in emergency settings.
Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang HW, Ketter T, Rudorfer MV, Wisniewski SR, Thase ME, Calabrese J, Sachs GS
Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord. 2004 Dec; 6(6):460-9.
Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry. 2005 Jul; 162(7):1281-90.
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000 Nov; 157(11):1873-5.
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
A clinical monitoring form for mood disorders. Bipolar Disord. 2002 Oct; 4(5):323-7.
A clinical monitoring form for mood disorders.
Canadian journal of psychiatry. Revue canadienne de psychiatrie
Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry. 1997 Mar; 42(2):196-9.
Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
Weight gain associated with use of psychotropic medications. J Clin Psychiatry. 1999; 60 Suppl 21:16-9.
Weight gain associated with use of psychotropic medications.
Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller RA, Bowden C
Journal of the American Academy of Child and Adolescent Psychiatry
An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002 Oct; 41(10):1224-30.
An open-label trial of divalproex in children and adolescents with bipolar disorder.
Deckersbach T, Savage CR, Dougherty DD, Bohne A, Loh R, Nierenberg A, Sachs G, Rauch SL
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder. Bipolar Disord. 2005 Apr; 7(2):166-75.
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder.
Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis. J Biol Chem. 2000 Feb 11; 275(6):4041-8.
Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis.
Pollack MH, Otto MW, Rosenbaum JF, Sachs GS
Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83.
Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity.
Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001 Jun; 158(6):906-12.
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Transition to mania during treatment of bipolar depression. Neuropsychopharmacology. 2010 Dec; 35(13):2545-52.
Transition to mania during treatment of bipolar depression.
Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg AA, Sachs GS
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther. 2012 Mar; 18(3):243-9.
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).
Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, Koukopoulos A, Yatham L, Grunze H
Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Br J Psychiatry. 2006 Dec; 189:515-9.
Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S, Miklowitz DJ, Sachs GS, Thase ME
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007 Sep; 164(9):1348-55.
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol. 1997 Jun; 17(3):185-9.
The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.
Vasile RG, Sachs G, Anderson JL, Lafer B, Matthews E, Hill T
Changes in regional cerebral blood flow following light treatment for seasonal affective disorder: responders versus nonresponders. Biol Psychiatry. 1997 Dec 01; 42(11):1000-5.
Changes in regional cerebral blood flow following light treatment for seasonal affective disorder: responders versus nonresponders.
Grandin LD, Yan LJ, Gray SM, Jamison KR, Sachs GS
Suicide prevention: increasing education and awareness. J Clin Psychiatry. 2001; 62 Suppl 25:12-6.
Suicide prevention: increasing education and awareness.
Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, Shelton MD, Goodwin FK, Frye MA, Kusumakar V
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry. 2002 Nov; 63(11):1012-9.
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder. J Affect Disord. 2003 Jan; 73(1-2):171-81.
Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder.
Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004 May 01; 55(9):875-81.
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand Suppl. 2004; (422):7-17.
Strategies for improving treatment of bipolar disorder: integration of measurement and management.
Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry. 2004 Oct; 161(10):1902-8.
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006 Feb; 163(2):210-6.
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Zeng N, Athmann C, Kang T, Lyu RM, Walsh JH, Ohning GV, Sachs G, Pisegna JR
PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest. 1999 Nov; 104(10):1383-91.
PACAP type I receptor activation regulates ECL cells and gastric acid secretion.
A 25-year-old woman with bipolar disorder. JAMA. 2001 Jan 24-31; 285(4):454-62.
A 25-year-old woman with bipolar disorder.
Muallem S, Loessberg P, Sachs G, Wheeler LA
Agonist-sensitive and -insensitive intracellular Ca2+ pools. Separate Ca(2+)-releasing mechanisms revealed by manoalide and benzohydroquinone. Biochem J. 1991 Oct 15; 279 ( Pt 2):367-75.
Agonist-sensitive and -insensitive intracellular Ca2+ pools. Separate Ca(2+)-releasing mechanisms revealed by manoalide and benzohydroquinone.
Major depression and the basal ganglia. Psychiatr Clin North Am. 1997 Dec; 20(4):885-96.
Frankle WG, Perlis RH, Deckersbach T, Grandin LD, Gray SM, Sachs GS, Nierenberg AA
Bipolar depression: relationship between episode length and antidepressant treatment. Psychol Med. 2002 Nov; 32(8):1417-23.
Bipolar depression: relationship between episode length and antidepressant treatment.
Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, Rauch SL, Dougherty D
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010 Oct; 16(5):298-307.
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms.
Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ
Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry. 2004 Dec; 65(12):1679-87.
Weight gain during treatment of bipolar I patients with olanzapine.
Martinez JM, Marangell LB, Simon NM, Miyahara S, Wisniewski SR, Harrington J, Pollack MH, Sachs GS, Thase ME
Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv. 2005 Dec; 56(12):1541-8.
Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.
Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disord. 2006 Feb; 8(1):75-80.
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Joffe H, Kim DR, Foris JM, Baldassano CF, Gyulai L, Hwang CH, McLaughlin WL, Sachs GS, Thase ME, Harlow BL, Cohen LS
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry. 2006 Feb; 67(2):297-304.
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.
Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. J Clin Psychopharmacol. 1990 Feb; 10(1):42-7.
Adjunctive clonazepam for maintenance treatment of bipolar affective disorder.
Wang PW, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Sagduyu K, Miyahara S, Ketter TA
Overweight and obesity in bipolar disorders. J Psychiatr Res. 2006 Dec; 40(8):762-4.
Overweight and obesity in bipolar disorders.
Melle-Milovanovic D, Milovanovic M, Nagpal S, Sachs G, Shin JM
Regions of association between the alpha and the beta subunit of the gastric H,K-ATPase. J Biol Chem. 1998 May 01; 273(18):11075-81.
Regions of association between the alpha and the beta subunit of the gastric H,K-ATPase.
Hofer A, Rettenbacher MA, Edlinger M, Huber R, Bodner T, Kemmler G, Sachs G, Fleischhacker WW
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine. Pharmacopsychiatry. 2007 Jan; 40(1):1-8.
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
Tamada RS, Issler CK, Amaral JA, Sachs GS, Lafer B
Treatment emergent affective switch: a controlled study. Bipolar Disord. 2004 Aug; 6(4):333-7.
Treatment emergent affective switch: a controlled study.
Nierenberg AA, Ostacher MJ, Borrelli DJ, Iosifescu DV, Perlis RH, Desrosiers A, Armistead MS, Calkins AW, Sachs GS
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry. 2006; 67 Suppl 11:3-7.
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007 Apr 26; 356(17):1711-22.
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
Pollack MH, Otto MW, Rosenbaum JF, Sachs GS, O'Neil C, Asher R, Meltzer-Brody S
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990 Dec; 51 Suppl A:12-6.
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 2000 Feb; 118(2 Suppl 1):S9-31.
Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.
Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med. 2000 Apr; Spec No:1-104.
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Deckersbach T, Rauch SL, Buhlmann U, Ostacher MJ, Beucke JC, Nierenberg AA, Sachs G, Dougherty DD
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report. Bipolar Disord. 2008 Dec; 10(8):928-42.
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report.
Zhao H, Loessberg PA, Sachs G, Muallem S
Regulation of intracellular Ca2+ oscillation in AR42J cells. J Biol Chem. 1990 Dec 05; 265(34):20856-62.
Regulation of intracellular Ca2+ oscillation in AR42J cells.
Mahableshwarkar AR, Calabrese JR, Macek TA, Budur K, Adefuye A, Dong X, Hanson E, Sachs GS
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. J Affect Disord. 2017 10 15; 221:275-282.
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.
Kogan JN, Bauer MS, Dennehy EB, Miklowitz DJ, Gonzalez JM, Thompson PM, Sachs GS
Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience. Clin Trials. 2009 Aug; 6(4):344-54.
Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience.
Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS
Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
Clonazepam in the treatment of panic disorder and agoraphobia.
Yildiz A, Moore CM, Sachs GS, Demopulos CM, Tunca Z, Erbayraktar Z, Renshaw PF
Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study. Psychiatry Res. 2005 Jan 30; 138(1):51-9.
Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study.
Goldberg JF, Allen MH, Miklowitz DA, Bowden CL, Endick CJ, Chessick CA, Wisniewski SR, Miyahara S, Sagduyu K, Thase ME, Calabrese JR, Sachs GS
Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr Serv. 2005 Dec; 56(12):1534-40.
Suicidal ideation and pharmacotherapy among STEP-BD patients.
Pollack MH, Sachs GS, Tesar GE, Shushtari J, Herman JB, Otto MW, Rosenbaum JF
Pilot outreach services to homebound agoraphobic patients. Hosp Community Psychiatry. 1991 Mar; 42(3):315-7.
Pilot outreach services to homebound agoraphobic patients.
Calabrese JR, Muzina DJ, Kemp DE, Sachs GS, Frye MA, Thompson TR, Klingman D, Reed ML, Hirschfeld RM
Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed. 2006 Aug 15; 8(3):38.
Predictors of bipolar disorder risk among patients currently treated for major depression.
Hirschfeld RM, Calabrese JR, Frye MA, Lavori PW, Sachs G, Thase ME, Wagner KD
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull. 2007; 40(3):7-14.
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.
International clinical psychopharmacology
Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol. 1997 Nov; 12(6):333-8.
Long-term risperidone treatment in bipolar disorder: 6-month follow up.
Sporn J, Ghaemi SN, Sambur MR, Rankin MA, Recht J, Sachs GS, Rosenbaum JF, Fava M
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry. 2000 Sep; 12(3):137-40.
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008 Sep; 40(9):1056-8.
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009 Jun; 11(4):391-400.
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Sachs GS, Pollack MH, Brotman AW, Farhadi AM, Gelenberg AJ
Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
Enhancement of ECT benefit by yohimbine.
Slyepchenko A, Frey BN, Lafer B, Nierenberg AA, Sachs GS, Dias RS
Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study. Acta Psychiatr Scand. 2017 11; 136(5):473-482.
Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.
Ketter TA, Sachs GS, Durgam S, Lu K, Starace A, Laszlovszky I, Németh G
The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. J Affect Disord. 2018 01 01; 225:350-356.
The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.
Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R
Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract. 2000 Jul; 6(4):197-211.
Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.
Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol. 1996 Apr; 16(2 Suppl 1):32S-47S.
Bipolar mood disorder: practical strategies for acute and maintenance phase treatment.
Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002 Dec; 63(12):1148-55.
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003 Jun 01; 53(11):1028-42.
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA
Journal of child and adolescent psychopharmacology
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol. 2003; 13(1):13-27.
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference.
Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003 Nov; 60(11):1079-88.
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Deckersbach T, Savage CR, Reilly-Harrington N, Clark L, Sachs G, Rauch SL
Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar Disord. 2004 Jun; 6(3):233-44.
Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies.
Baldassano CF, Marangell LB, Gyulai L, Ghaemi SN, Joffe H, Kim DR, Sagduyu K, Truman CJ, Wisniewski SR, Sachs GS, Cohen LS
Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005 Oct; 7(5):465-70.
Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants.
Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007 Apr; 64(4):419-26.
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
Expression of gastric and colonic H(+)-K(+)-ATPase in the rat kidney. Am J Physiol. 1995 Apr; 268(4 Pt 2):F581-7.
Expression of gastric and colonic H(+)-K(+)-ATPase in the rat kidney.
Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, Rosenbaum JF
Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 2002 Jul; 159(7):1155-9.
Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data.
Kraut JA, Helander KG, Helander HF, Iroezi ND, Marcus EA, Sachs G
American journal of physiology. Renal physiology
Detection and localization of H+-K+-ATPase isoforms in human kidney. Am J Physiol Renal Physiol. 2001 Oct; 281(4):F763-8.
Detection and localization of H+-K+-ATPase isoforms in human kidney.
Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R, Sonawalla S, Rosenbaum JF
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res. 2003 May-Jun; 37(3):187-92.
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression.
Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE
Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biol Psychiatry. 2006 Dec 15; 60(12):1378-81.
Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
Marangell LB, Bauer MS, Dennehy EB, Wisniewski SR, Allen MH, Miklowitz DJ, Oquendo MA, Frank E, Perlis RH, Martinez JM, Fagiolini A, Otto MW, Chessick CA, Zboyan HA, Miyahara S, Sachs G, Thase ME
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 2006 Oct; 8(5 Pt 2):566-75.
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.
Bipolar disorder: current treatments and new strategies. Cleve Clin J Med. 1998; 65 Suppl 1:SI31-7; discussion SI45-7.
Bipolar disorder: current treatments and new strategies.
Progress in neuro-psychopharmacology & biological psychiatry
Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct; 26(6):1035-9.
Prog Neuropsychopharmacol Biol Psychiatry
Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions.
A review of agitation in mental illness: burden of illness and underlying pathology. J Clin Psychiatry. 2006; 67 Suppl 10:5-12.
A review of agitation in mental illness: burden of illness and underlying pathology.
Update on bipolar disorder and substance abuse: recent findings and treatment strategies. J Clin Psychiatry. 2006 Sep; 67(9):e10.
Update on bipolar disorder and substance abuse: recent findings and treatment strategies.
Bipolar-I depression outpatient treatment quality and costs in usual care practice. Psychopharmacol Bull. 2008; 41(2):24-39.
Bipolar-I depression outpatient treatment quality and costs in usual care practice.
Perlick DA, Rosenheck RA, Miklowitz DJ, Kaczynski R, Link B, Ketter T, Wisniewski S, Wolff N, Sachs G
The Journal of nervous and mental disease
Caregiver burden and health in bipolar disorder: a cluster analytic approach. J Nerv Ment Dis. 2008 Jun; 196(6):484-91.
Caregiver burden and health in bipolar disorder: a cluster analytic approach.
Decision tree for the treatment of bipolar disorder. J Clin Psychiatry. 2003; 64 Suppl 8:35-40.
Decision tree for the treatment of bipolar disorder.
Calabrese JR, Keck PE, Bowden CL, Ketter TA, Sachs G, Findling RL, Sajatovic M
A US perspective of the CANMAT bipolar guidelines. Bipolar Disord. 2005; 7 Suppl 3:70-2.
A US perspective of the CANMAT bipolar guidelines.
Suppes T, Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005 Jul; 66(7):870-86.
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict. 2006 Mar-Apr; 15(2):138-43.
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.
Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry. 2006 Jul; 163(7):1199-201.
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
Sachs GS, Baldassano CF, Truman CJ, Guille C
Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry. 2000 Mar; 157(3):466-8.
Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder.
Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry. 2000 Sep 15; 48(6):558-72.
Bipolar depression: pharmacotherapy and related therapeutic strategies.
Administration of antidepressants. Single versus split dosing: a meta-analysis. J Affect Disord. 2001 Oct; 66(2-3):199-206.
Administration of antidepressants. Single versus split dosing: a meta-analysis.
Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, Keck PE, Kirsch I, Krishnan KR, Kupfer DJ, Makuch RW, Miller FG, Pardes H, Post R, Reynolds MM, Roberts L, Rosenbaum JF, Rosenstein DL, Rubinow DR, Rush AJ, Ryan ND, Sachs GS, Schatzberg AF, Solomon S
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry. 2002 Mar; 59(3):262-70.
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Age onset of psychotic versus non-psychotic bipolar illness in men and in women. J Affect Disord. 2003 Apr; 74(2):197-201.
Age onset of psychotic versus non-psychotic bipolar illness in men and in women.
Rates of study completion with single versus split daily dosing of antidepressants: a meta-analysis. J Affect Disord. 2004 Feb; 78(2):157-62.
Rates of study completion with single versus split daily dosing of antidepressants: a meta-analysis.
Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004 Dec; 161(12):2222-9.
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Perlis RH, Delbello MP, Miyahara S, Wisniewski SR, Sachs GS, Nierenberg AA
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry. 2005 Oct 01; 58(7):549-53.
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants.
Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, Nierenberg AA, Sachs GS
Inositol augmentation of lithium or valproate for bipolar depression. Bipolar Disord. 2006 Apr; 8(2):168-74.
Inositol augmentation of lithium or valproate for bipolar depression.
Truman CJ, Goldberg JF, Ghaemi SN, Baldassano CF, Wisniewski SR, Dennehy EB, Thase ME, Sachs GS
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2007 Oct; 68(10):1472-9.
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Weilburg JB, Schachter S, Worth J, Pollack MH, Sachs GS, Ives JR, Schomer DL
EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62.
EEG abnormalities in patients with atypical panic attacks.
Labbate LA, Lafer B, Thibault A, Rosenbaum JF, Sachs GS
Influence of phototherapy treatment duration for seasonal affective disorder: outcome at one vs. two weeks. Biol Psychiatry. 1995 Dec 01; 38(11):747-50.
Influence of phototherapy treatment duration for seasonal affective disorder: outcome at one vs. two weeks.
Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH
Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34.
Brain GABA levels in patients with bipolar disorder.
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009 Sep; 11(6):559-95.
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.
Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, Nierenberg AA
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci Ther. 2009; 15(4):309-19.
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
Dennehy EB, Bauer MS, Perlis RH, Kogan JN, Sachs GS
Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull. 2007; 40(3):72-84.
Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder.
Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM
Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008 Jun; 13(6):558-69.
Whole-genome association study of bipolar disorder.
Gyulai L, Bauer MS, Marangell LB, Dennehy EB, Thase ME, Otto MW, Zhang H, Wisniewski SR, Miklowitz DJ, Rapaport MH, Baldassano CF, Sachs GS
Correlates of functioning in bipolar disorder. Psychopharmacol Bull. 2008; 41(4):51-64.
Correlates of functioning in bipolar disorder.
Ostacher MJ, Lebeau RT, Perlis RH, Nierenberg AA, Lund HG, Moshier SJ, Sachs GS, Simon NM
Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009 Nov; 11(7):766-71.
Cigarette smoking is associated with suicidality in bipolar disorder.
Perlis RH, Ostacher MJ, Miklowitz DJ, Smoller JW, Dennehy EB, Cowperthwait C, Nierenberg AA, Thase ME, Sachs GS
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry. 2010 Feb; 71(2):194-200.
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
Dias RS, Lafer B, Russo C, Del Debbio A, Nierenberg AA, Sachs GS, Joffe H
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry. 2011 Apr; 168(4):386-94.
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD.
Labbate LA, Lafer B, Thibault A, Sachs GS
Side effects induced by bright light treatment for seasonal affective disorder. J Clin Psychiatry. 1994 May; 55(5):189-91.
Side effects induced by bright light treatment for seasonal affective disorder.
Goldberg JF, Brooks JO, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009 Feb; 70(2):155-62.
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J Clin Psychiatry. 1989 Dec; 50 Suppl:31-9; discussion 45-7.
Adjuncts and alternatives to lithium therapy for bipolar affective disorder.
Reilly-Harrington NA, DeBonis D, Leon AC, Sylvia L, Perlis R, Lewis D, Sachs GS
The interactive computer interview for mania. Bipolar Disord. 2010 Aug; 12(5):521-7.
The interactive computer interview for mania.
Reilly-Harrington NA, Deckersbach T, Knauz R, Wu Y, Tran T, Eidelman P, Lund HG, Sachs G, Nierenberg AA
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study. J Psychiatr Pract. 2007 Sep; 13(5):291-7.
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
Perlis RH, Ostacher MJ, Uher R, Nierenberg AA, Casamassima F, Kansky C, Calabrese JR, Thase M, Sachs GS
Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disord. 2009 Dec; 11(8):867-75.
Stability of symptoms across major depressive episodes in bipolar disorder.
Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Tran QV, Pikalov A, Assunção-Talbott S
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J Psychopharmacol. 2010 Jul; 24(7):1019-29.
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, Nierenberg AA, Sachs G, Nimgaonkar VL, Miklowitz DJ, Smoller JW
Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011 Aug; 41(8):1593-604.
Personality and bipolar disorder: dissecting state and trait associations between mood and personality.
The pharmacologic treatment of bipolar disorder. J Clin Psychiatry. 2011 May; 72(5):704-15.
The pharmacologic treatment of bipolar disorder.
Donepezil in treatment-resistant bipolar disorder. Biol Psychiatry. 1999 Apr 15; 45(8):959-64.
Donepezil in treatment-resistant bipolar disorder.
Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry. 2000 Sep 15; 48(6):573-81.
Bipolar disorder therapeutics: maintenance treatment.
Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003 Apr; 60(4):392-400.
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003 Sep; 64(9):1013-24.
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Perlis RH, Smoller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord. 2004 Apr; 79(1-3):291-5.
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder.
Lembke A, Miklowitz DJ, Otto MW, Zhang H, Wisniewski SR, Sachs GS, Thase ME, Ketter TA
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. J Psychiatr Pract. 2004 Mar; 10(2):81-7.
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999 Feb; 60(2):79-88.
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Use of clonazepam for bipolar affective disorder. J Clin Psychiatry. 1990 May; 51 Suppl:31-4; discussion 50-3.
Use of clonazepam for bipolar affective disorder.
Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76.
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Deckersbach T, Dougherty DD, Savage C, McMurrich S, Fischman AJ, Nierenberg A, Sachs G, Rauch SL
Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder. Biol Psychiatry. 2006 Jan 15; 59(2):138-46.
Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder.
Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry. 2006 Feb; 163(2):247-56.
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
Bauer MS, McBride L, Chase C, Sachs G, Shea N
Manual-based group psychotherapy for bipolar disorder: a feasibility study. J Clin Psychiatry. 1998 Sep; 59(9):449-55.
Manual-based group psychotherapy for bipolar disorder: a feasibility study.